Stockreport

A Look At CytomX Therapeutics (CTMX) Valuation After Positive Varsetatug Masetecan Phase 1 Expansion Results [Yahoo! Finance]

CytomX Therapeutics, Inc.  (CTMX) 
Last cytomx therapeutics, inc. earnings: 11/7 04:09 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.cytomx.com
PDF CytomX Therapeutics (CTMX) is back in focus after reporting early Phase 1 expansion results for its EpCAM-targeting ADC, Varsetatug masetecan, in advanced colorectal ca [Read more]